Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking
José Luis Vique‐Sánchez
Topics & Concepts
Neuropilin 1ChemistryDocking (animal)ADMEAdjuvantCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Virtual screeningComputational biologyDrugPharmacologyDrug discoveryBiochemistryIn vitroBiologyCancer researchInfectious disease (medical specialty)MedicineImmunologyPathologyNursingVEGF receptorsDiseaseVascular endothelial growth factorApelin-related biomedical researchAngiogenesis and VEGF in CancerAxon Guidance and Neuronal Signaling